Market Price

58.77 

1.04 1.8%

as of May 14 '21

52 Week Range:

34.48 63.85


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 7.50
8.70
10.11
12.58
15.92
15.37
16.24
13.64
15.02
15.21
16.26
growth rate 16.0% 16.2% 24.4% 26.6% -3.5% 5.7% -16.0% 10.1% 1.3% 6.9%
Earnings BIT 207.61
226.77
345.24
556.94
352.19
244.70
262.50
274.48
311.55
267.43
257.56
growth rate 9.2% 52.2% 61.3% -36.8% -30.5% 7.3% 4.6% 13.5% -14.2% -3.7%
Avg.PE 14.35
20.45
10.54
23.26
17.46
12.50
19.87
30.24
29.38
29.38
29.38
growth rate 42.5% -48.5% 120.7% -24.9% -28.4% 59.0% 52.2% -2.8% 0.0% 0.0%
ROA 16.58
16.28
20.68
24.54
11.01
8.53
9.60
8.45
7.42
10.02
10.27
growth rate -1.8% 27.0% 18.7% -55.1% -22.5% 12.5% -12.0% -12.2% 35.0% 2.5%
ROE 32.13
29.33
38.06
50.36
21.01
15.05
19.21
18.91
16.40
20.95
21.63
growth rate -8.7% 29.8% 32.3% -58.3% -28.4% 27.6% -1.6% -13.3% 27.7% 3.3%
ROIC 24.15
23.32
29.64
39.99
16.97
11.75
13.27
11.91
10.57
13.38
13.78
growth rate -3.4% 27.1% 34.9% -57.6% -30.8% 12.9% -10.3% -11.3% 26.6% 3.0%
Cur. Ratio 1.95
2.19
1.87
1.44
2.00
1.73
1.79
1.74
1.82
2.07
1.66
growth rate 12.3% -14.6% -23.0% 38.9% -13.5% 3.5% -2.8% 4.6% 13.7% -19.8%
Quick Ratio 1.18
1.34
1.16
0.79
0.80
0.83
1.00
1.05
1.02
1.11
0.90
growth rate 13.6% -13.4% -31.9% 1.3% 3.8% 20.5% 5.0% -2.9% 8.8% -18.9%
Leverage 1.89
1.73
1.95
2.12
1.71
1.82
2.22
2.26
2.17
2.02
2.19
growth rate -8.5% 12.7% 8.7% -19.3% 6.4% 22.0% 1.8% -4.0% -6.9% 8.4%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 25.70
31.62
36.85
68.65
35.83
35.46
31.20
33.20
53.28
50.38
63.37
growth rate 23.0% 16.6% 86.3% -47.8% -1.0% -12.0% 6.4% 60.5% -5.5% 25.8%
Acct.Payable 212.56
281.08
708.97
34.71
28.83
41.26
50.34
47.62
38.98
66.17
growth rate 32.2% 152.2% -95.1% -16.9% 43.1% 22.0% -5.4% -18.1% 69.8%
Cur.Assets 422.50
530.09
588.60
1,118.33
834.67
706.39
714.34
777.79
799.24
740.17
903.20
growth rate 25.5% 11.0% 90.0% -25.4% -15.4% 1.1% 8.9% 2.8% -7.4% 22.0%
Total Assets 892.20
990.96
1,124.81
1,821.06
1,614.43
1,505.84
1,474.05
1,589.87
1,694.45
1,769.01
1,957.08
growth rate 11.1% 13.5% 61.9% -11.4% -6.7% -2.1% 7.9% 6.6% 4.4% 10.6%
Cash 230.30
272.97
320.03
525.15
288.42
289.35
357.25
426.40
386.91
335.63
402.68
growth rate 18.5% 17.2% 64.1% -45.1% 0.3% 23.5% 19.4% -9.3% -13.3% 20.0%
Inventory 114.50
112.11
135.87
339.67
338.49
265.26
260.79
262.85
298.63
280.17
318.49
growth rate -2.1% 21.2% 150.0% -0.4% -21.6% -1.7% 0.8% 13.6% -6.2% 13.7%
Cur.Liabilities 216.40
241.17
320.10
776.79
418.33
407.60
399.01
447.37
439.66
356.76
542.86
growth rate 11.5% 32.7% 142.7% -46.2% -2.6% -2.1% 12.1% -1.7% -18.9% 52.2%
Liabilities 421.00
416.72
534.20
962.44
672.00
680.22
809.98
885.28
912.58
893.72
1,062.81
growth rate -1.0% 28.2% 80.2% -30.2% 1.2% 19.1% 9.3% 3.1% -2.1% 18.9%
LT Debt 133.00
107.94
154.96
113.85
164.57
181.75
334.17
310.79
361.01
334.46
305.39
growth rate -18.8% 43.6% -26.5% 44.5% 10.4% 83.9% -7.0% 16.2% -7.4% -8.7%
Equity 471.20
574.24
590.61
858.62
942.44
825.62
664.07
704.60
781.87
875.29
894.27
growth rate 21.9% 2.9% 45.4% 9.8% -12.4% -19.6% 6.1% 11.0% 12.0% 2.2%
Common Shares 65.00
65.00
63.00
61.00
61.00
59.00
56.00
55.00
56.00
56.00
53.00
growth rate 0.0% -3.1% -3.2% 0.0% -3.3% -5.1% -1.8% 1.8% 0.0% -5.4%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 53.80
41.81
96.65
185.10
101.48
56.62
50.22
60.16
70.37
66.07
63.82
growth rate -22.3% 131.2% 91.5% -45.2% -44.2% -11.3% 19.8% 17.0% -6.1% -3.4%
Cash Dividends 31.20
36.64
48.37
70.51
81.37
81.19
78.44
76.06
80.58
82.19
78.39
growth rate 17.4% 32.0% 45.8% 15.4% -0.2% -3.4% -3.0% 6.0% 2.0% -4.6%
Cash From OA 187.90
224.32
310.98
530.18
-56.46
322.11
275.26
302.56
202.74
177.93
379.14
growth rate 19.4% 38.6% 70.5% -100.0% 100.0% -14.5% 9.9% -33.0% -12.2% 113.1%
FCF per Share 2.08
1.92
3.40
6.22
-3.71
4.54
3.84
3.51
3.49
2.43
5.08
growth rate -7.7% 77.1% 82.9% -100.0% 100.0% -15.4% -8.6% -0.6% -30.4% 109.1%
Sale Purchase of Stock -37.44
-196.91
-106.50
3.32
3.32
14.31
24.44
growth rate 0.0% 0.0% 100.0% 0.0% 331.6% 70.9%
FCF 134.00
183.00
214.00
345.00
-158.00
265.00
225.00
242.00
132.00
112.00
315.00
growth rate 36.6% 16.9% 61.2% -100.0% 100.0% -15.1% 7.6% -45.5% -15.2% 181.3%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 1,537.30
1,719.59
2,132.26
3,176.72
2,569.50
2,247.05
2,207.80
2,279.10
2,679.01
2,420.42
2,581.93
growth rate 11.9% 24.0% 49.0% -19.1% -12.6% -1.8% 3.2% 17.6% -9.7% 6.7%
Op.Income 217.10
153.33
221.65
364.89
352.19
244.70
262.50
274.48
311.55
267.43
257.56
growth rate -29.4% 44.6% 64.6% -3.5% -30.5% 7.3% 4.6% 13.5% -14.2% -3.7%
IBT 207.60
226.77
345.24
556.94
298.51
211.96
212.84
265.57
219.67
255.17
256.23
growth rate 9.2% 52.2% 61.3% -46.4% -29.0% 0.4% 24.8% -17.3% 16.2% 0.4%
Net Income 136.10
153.33
221.65
364.89
189.18
133.05
143.09
129.44
121.89
173.55
191.36
growth rate 12.7% 44.6% 64.6% -48.2% -29.7% 7.6% -9.5% -5.8% 42.4% 10.3%
EPS 2.11
2.38
3.52
5.94
3.11
2.25
2.55
2.36
2.16
3.10
3.63
growth rate 12.8% 47.9% 68.8% -47.6% -27.7% 13.3% -7.5% -8.5% 43.5% 17.1%
Gross Profit 1,264.80
1,396.96
1,779.11
2,670.91
2,091.06
1,757.54
1,738.74
1,777.02
2,044.87
1,839.00
1,923.91
growth rate 10.5% 27.4% 50.1% -21.7% -16.0% -1.1% 2.2% 15.1% -10.1% 4.6%
R&D 23.00
30.10
23.30
growth rate 30.9% -22.6%

Quarterly Statements

Item Name Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Earnings BIT 36.57
58.07
74.23
88.70
62.91
growth rate 58.8% 27.8% 19.5% -29.1%
Balance Sheet Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Acct.Receivable 43.97
64.37
60.02
63.37
60.63
growth rate 46.4% -6.8% 5.6% -4.3%
Acct.Payable 39.89
51.66
55.30
66.17
67.08
growth rate 29.5% 7.1% 19.7% 1.4%
Cur.Assets 729.57
785.84
772.26
903.20
900.89
growth rate 7.7% -1.7% 17.0% -0.3%
Total Assets 1,746.32
1,794.49
1,816.71
1,957.08
1,950.10
growth rate 2.8% 1.2% 7.7% -0.4%
Cash 352.58
375.51
366.71
402.68
339.10
growth rate 6.5% -2.3% 9.8% -15.8%
Inventory 257.47
261.97
270.32
318.49
363.43
growth rate 1.8% 3.2% 17.8% 14.1%
Cur.Liabilities 420.10
484.64
466.35
542.86
561.58
growth rate 15.4% -3.8% 16.4% 3.5%
Liabilities 945.82
1,002.48
989.24
1,062.81
1,078.63
growth rate 6.0% -1.3% 7.4% 1.5%
LT Debt 327.20
319.93
312.66
305.39
298.12
growth rate -2.2% -2.3% -2.3% -2.4%
Equity 800.50
792.01
827.47
894.27
871.47
growth rate -1.1% 4.5% 8.1% -2.6%
Common Shares 0.09
0.09
0.09
0.09
0.09
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Capital Expenditures 19.39
9.31
20.12
15.01
growth rate -52.0% 116.2% -25.4%
Cash Dividends 20.69
19.36
19.25
19.10
growth rate -6.4% -0.6% -0.8%
Cash From OA 69.03
97.05
118.37
94.69
-18.86
growth rate 40.6% 22.0% -20.0% -100.0%
Sale Purchase of Stock
growth rate
FCF 49.64
87.75
98.25
79.68
growth rate 76.8% 12.0% -18.9%
Income Statement Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Sales 518.03
612.37
703.35
748.19
677.03
growth rate 18.2% 14.9% 6.4% -9.5%
Op.Income 36.57
58.07
74.23
88.70
62.91
growth rate 58.8% 27.8% 19.5% -29.1%
IBT 30.39
59.66
74.75
91.43
64.50
growth rate 96.3% 25.3% 22.3% -29.5%
Net Income 19.73
41.85
56.31
73.47
47.43
growth rate 112.1% 34.5% 30.5% -35.4%
EPS
growth rate
Gross Profit 392.24
458.26
519.97
553.44
506.46
growth rate 16.8% 13.5% 6.4% -8.5%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (55.95)

YOY Growth Grade:

D (37.66)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 29.38 22.47 18.39
EPS / Growth -10.8% 2.62 8.8%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 4.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 2.7% 2.7%
Future PE 2.00 17.70 17.70
Future EPS 2.89 3.40 3.40
Value Price
MOS %
1.43
-97.6%
14.90
-74.7%
14.90
-74.7%
MOS Price 0.71 7.45 7.45
IRT 20.18 17.46 17.46

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.